Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recovery Initiation and Management After Overdose (RIMO) Experiment: Phase 2 Main Clinical Trial (R33)

NCT03895827 is registered in ClinicalTrials.gov with Chestnut Health Systems as lead sponsor.

NCT NCT03895827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03895827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recovery Initiation and Management After Overdose (RIMO) Experiment: Phase 2 Main Clinical Trial (R33)
Lead sponsor
Chestnut Health Systems
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2022
Completion date
June 26, 2025
Enrollment
251 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid-use disorder